B. C. Dow
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 31
- Hepatitis C virus research 30
- Epidemiology 30
- Hepatitis B Virus Studies 28
- Liver Disease Diagnosis and Treatment 10
- Co-authors
- E. A. C. Follett (15 shared papers)F. McOmish (8 shared papers)Peter Simmonds (12 shared papers)Shiu‐Wan Chan (3 shared papers)P.L. Yap (5 shared papers)P.L. Yap (3 shared papers)Edward C. Holmes (1 shared paper)J F Peutherer (1 shared paper)
- Journals
- Vox Sanguinis (14 papers)Journal of Medical Virology (5 papers)Journal of Clinical Pathology (5 papers)Transfusion (4 papers)Transfusion Medicine (4 papers)
- Partner nations
- United KingdomUnited StatesSlovakia
In The Last Decade
B. C. Dow
43 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 93
- Hepatology 1.8k
- Epidemiology 1.6k
- Virology 71
- Infectious Diseases 243
- Management of Technology and Innovation 77
Countries citing papers authored by B. C. Dow
This map shows the geographic impact of B. C. Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. C. Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. C. Dow more than expected).
Fields of papers citing papers by B. C. Dow
This network shows the impact of papers produced by B. C. Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. C. Dow. The network helps show where B. C. Dow may publish in the future.
Co-authors
The 25 scholars most cited alongside B. C. Dow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 443 | |
| 2 | 1992 | 372 | |
| 3 | 1993 | 258 | |
| 4 | 1993 | 216 | |
| 5 | 1990 | 127 | |
| 6 | 2005 | 80 | |
| 7 | 1996 | 43 | |
| 8 | 2004 | 43 | |
| 9 | 1996 | 42 | |
| 10 | 1992 | 37 | |
| 11 | 1994 | 36 | |
| 12 | 1993 | 35 | |
| 13 | 1995 | 29 | |
| 14 | 1999 | 29 | |
| 15 | 1994 | 29 | |
| 16 | 2005 | 26 | |
| 17 | 2002 | 23 | |
| 18 | 2002 | 22 | |
| 19 | 2005 | 22 | |
| 20 | 2009 | 18 |
About B. C. Dow
B. C. Dow is a scholar working on Hepatology, Epidemiology, Management of Technology and Innovation, Hematology and Infectious Diseases, having authored 44 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (28 papers), Liver Disease Diagnosis and Treatment (10 papers), Blood groups and transfusion (6 papers), Blood donation and transfusion practices (6 papers), T-cell and Retrovirus Studies (4 papers), Systemic Lupus Erythematosus Research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.6k citations), Virology (71 citations), Infectious Diseases (243 citations) and Management of Technology and Innovation (77 citations). B. C. Dow has collaborated with scholars based in United Kingdom, United States and Slovakia. Frequent co-authors include E. A. C. Follett, F. McOmish, Peter Simmonds, Shiu‐Wan Chan, P.L. Yap, P.L. Yap, Edward C. Holmes, J F Peutherer, Elina Kolho and Clive R. Seed. Their work appears in journals such as Vox Sanguinis, Journal of Medical Virology, Journal of Clinical Pathology, Transfusion and Transfusion Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.